Heron Therapeutics, INC. /De/ (HRTX) SEC Filings — 2024
22 SEC filings for Heron Therapeutics, INC. /De/ (HRTX) in 2024.
Filings
- Heron Therapeutics Files 8-K — 8-K · Dec 23, 2024
- Gilead to Acquire Heron Therapeutics for $1.2 Billion — 8-K · Dec 3, 2024
- Heron Therapeutics, INC. /De/ SC 13G Filing — SC 13G · Nov 12, 2024
- Heron Therapeutics Files Q3 2024 10-Q Report — 10-Q · Nov 12, 2024
- Heron Therapeutics, INC. /De/ SC 13G Filing — SC 13G · Nov 8, 2024
- Heron Therapeutics Appoints New Chief Medical Officer — 8-K · Nov 4, 2024
- Heron Therapeutics, INC. /De/ SC 13G Filing — SC 13G · Oct 24, 2024
- Heron Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
- Heron Therapeutics Files 8-K Report — 8-K · Jul 2, 2024
- Heron Therapeutics Announces Corporate Changes — 8-K · Jun 18, 2024
- Rubric Capital Boosts Heron Therapeutics Stake to 10.4% — SC 13D/A · May 31, 2024
- Heron Therapeutics Files 8-K — 8-K · May 29, 2024
- Heron Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Heron Therapeutics Announces 2024 Annual Meeting of Stockholders on June 13, 2024 — DEF 14A · Apr 29, 2024
- Heron Therapeutics Announces Board and Executive Compensation Changes — 8-K · Mar 21, 2024
- HERON THERAPEUTICS, INC. /DE/ Files 2023 Annual Report on Form 10-K — 10-K · Mar 12, 2024
- Heron Therapeutics, INC. /De/ SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Heron Therapeutics, INC. /De/ SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Vanguard Group Amends Heron Therapeutics Stake to 9.9% — SC 13G/A · Feb 13, 2024
- Franklin Resources Amends Heron Therapeutics Stake as of Dec 31, 2023 — SC 13G/A · Feb 6, 2024
- Heron Therapeutics Files Routine 8-K, Confirms Nasdaq Listing — 8-K · Jan 24, 2024
- Heron Therapeutics Reports Undisclosed Material Definitive Agreement — 8-K · Jan 11, 2024